← Back to Clinical Trials
Recruiting NCT07294183

NCT07294183 The Effect of Emotion-Focused Intervention on Emotion Regulation and Well-Being of Individuals With Transplantation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07294183
Status Recruiting
Phase
Sponsor Akdeniz University
Condition Renal Transplantation
Study Type INTERVENTIONAL
Enrollment 56 participants
Start Date 2025-07-01
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Emotion-Focused Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 56 participants in total. It began in 2025-07-01 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study was designed to evaluate the effects of an emotion-focused intervention based on the Human-to-Human Relationship Model on emotion regulation skills and well-being in individuals who have undergone renal transplantation. This study was designed as a single-blind randomized controlled trial with a pretest, posttest, and follow-up control group design. Based on the data obtained from the study, the impact of an emotion-focused intervention based on the Human-to-Human Relationship Model on emotion regulation skills and well-being in individuals who have undergone renal transplantation will be evaluated.

Eligibility Criteria

Inclusion Criteria: * Volunteering to participate in the study * Having a renal transplant * Being over 18 years of age * Being literate Exclusion Criteria: * Having any communication disability (reading, hearing, speaking, etc.) * Participation in another study simultaneously with this study outside of routine clinical practice * Having another neurological or psychiatric diagnosis affecting cognitive status * Having previously undergone a renal transplant * Having undergone multiple organ transplant

Contact & Investigator

Central Contact

Esra ÇELİK, RA

✉ esrac@akdeniz.edu.tr

📞 2422261358

Principal Investigator

Esra ÇELİK

PRINCIPAL INVESTIGATOR

Akdeniz University Faculty of Nursing

Frequently Asked Questions

Who can join the NCT07294183 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Renal Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07294183 currently recruiting?

Yes, NCT07294183 is actively recruiting participants. Contact the research team at esrac@akdeniz.edu.tr for enrollment information.

Where is the NCT07294183 trial being conducted?

This trial is being conducted at Antalya, Turkey (Türkiye).

Who is sponsoring the NCT07294183 clinical trial?

NCT07294183 is sponsored by Akdeniz University. The principal investigator is Esra ÇELİK at Akdeniz University Faculty of Nursing. The trial plans to enroll 56 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology